AGP Executive Report
Last update: 8 hours agoFDA & Obesity Drugs: Novo Nordisk’s Wegovy just got a faster path again—FDA approved “Wegovy HD,” a higher 7.2 mg once-weekly dose, using the agency’s expedited voucher program that can cut reviews to about 1–2 months. Medicaid & Rural Care: In Ohio, a rural hospital CEO is warning that billions in Medicaid money could be lost to fraud—and argues even small savings could help stabilize rural hospitals. Workforce & Infection Control: The UK’s Royal College of Physicians is sounding the alarm on infection-specialist shortages, citing rising antimicrobial resistance and the ongoing risk of future pandemics. Pharmacy Access vs Safety: Across India, chemists’ strikes targeting e-pharmacies are shutting thousands of stores, with patients scrambling for refills and pharmacists warning about counterfeit and unsafe online sales. AI in Medicine: The AMA says AI should complement—not replace—doctors, urging patients to use chatbots for exploring options while keeping clinical decisions with clinicians. Global Pharma Moves: Hanmi Pharmaceutical and Organon signed a deal to export combination therapies to Malaysia and the Philippines.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
Pseudo-journalism: Pink-slime
